Chiesi Group Bets Big on Salesforce Agentforce Life Sciences to Reinvent Pharma Customer Engagement
International biopharmaceutical group Chiesi has signed on for Salesforce Agentforce Life Sciences for Customer Engagement, joining a growing list of pharma companies moving off legacy CRM and onto AI-native platforms. The agreement, announced on April 20, will roll Agentforce out to 3,300 users across Chiesi’s global markets and stitch together commercial operations, medical affairs, and marketing on a single platform.
Why Chiesi Moved Now
Chiesi’s selection is one of the most visible industry wins for Salesforce’s life sciences stack, and it speaks to a broader shift: pharma commercial teams want a CRM that does more than store activity records. They want a system that surfaces the next best action and drafts the tedious parts of the job – call notes, summaries, cycle plans – so reps can spend their limited time with physicians actually talking about science.
Joe Ferraro, SVP and GM of Agentforce Life Sciences at Salesforce, framed the deal as a vote of confidence in AI-native CRM: legacy systems weren’t built for agentic workflows, and retrofitting them has limits. For Chiesi, replacing a decade-old customer engagement stack with a platform that natively embeds Agentforce into the rep’s daily flow was the shortcut.
A Single View of the HCP
The foundation of the deployment is Salesforce Data Cloud – branded Data 360 in the life sciences configuration – which Chiesi will use to consolidate customer data into one trusted profile per healthcare professional, hospital, and pharmacy. Field interactions, medical affairs activities, multichannel campaign signals, and business operations data all flow into the same profile layer.
That matters because life sciences companies have historically struggled with fragmented customer records: a rep might see one version of a physician, the medical team another, and marketing a third. Data 360 is intended to collapse those views. Once the data is harmonized, it becomes fuel for Agentforce – agents can only be as useful as the data they can reason over.
Agentforce-Powered Field Teams
The most visible change for Chiesi’s reps will show up in their daily prep. Under the new model, an Agentforce assistant prepares reps for customer visits with AI-generated suggestions and pre-meeting summaries, then helps with post-call work like drafting notes and updating cycle plans. Cloud Wars characterized this kind of deployment as part of a broader partner and customer push in MedTech and pharma, where the bottleneck for AI adoption is often integration and domain-specific workflow design rather than the model itself.
Marketing Cloud Joins the Mix
The deployment doesn’t stop at field enablement. Chiesi is also using Agentforce Marketing to run multichannel campaigns alongside its HCP engagement and event coordination work, tying Marketing Cloud orchestration to the same unified profile. For pharma, this is a meaningful step: medical congresses, scientific communications, and digital outreach have historically been run on separate tools, with separate metrics. Chiesi is effectively wiring event coordination, journey orchestration, and field engagement into one lifecycle view.
What This Signals for the Industry
Three things stand out. First, Agentforce Life Sciences is graduating from early adopter deployments to full-scale commercial rollouts at established biopharma companies. Second, Data Cloud is increasingly the non-negotiable foundation for any serious Salesforce AI deployment – Agentforce without harmonized data is a demo, not a production system. And third, Salesforce is bundling the stack: CRM, Data 360, and Marketing Cloud are being sold and deployed together, not as loose components.
For pharma and medtech executives watching from the sidelines, the Chiesi deal lowers the “is this ready for us?” bar. A 3,300-user, multi-market rollout is no longer a pilot – it’s a reference architecture. Expect competitors to Veeva and other life sciences CRMs to feel the heat as Salesforce leans further into industry-specific Agentforce SKUs through the rest of 2026.
Share With Others
